89 related articles for article (PubMed ID: 30822244)
1. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
Topic A; Milovanovic V; Lazic Z; Ivosevic A; Radojkovic D
COPD; 2018 Oct; 15(5):472-478. PubMed ID: 30822244
[TBL] [Abstract][Full Text] [Related]
2. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with functional activity and oxidative modification of alpha-1-antitrypsin in COPD patients.
Milovanovic V; Topic A; Milinkovic N; Lazic Z; Ivosevic A; Radojkovic D; Rankov AD
Pulmonology; 2024; 30(2):122-129. PubMed ID: 34674978
[TBL] [Abstract][Full Text] [Related]
3. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
4. Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.
Greulich T; Vogelmeier CF
Ther Adv Respir Dis; 2016 Feb; 10(1):72-84. PubMed ID: 26341117
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools.
Sapey E; Crowley LE; Edgar RG; Griffiths D; Samanta S; Crisford H; Bolton CE; Hurst JR; Stockley RA
Orphanet J Rare Dis; 2024 Mar; 19(1):130. PubMed ID: 38515138
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of alpha-1-antitrypsin levels in blood serum of patients with chronic obstructive pulmonary disease.
Perincek G; Avcı S
Acta Biomed; 2018 Oct; 90(1):37-43. PubMed ID: 30889153
[TBL] [Abstract][Full Text] [Related]
7. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.
Andelid K; Andersson A; Yoshihara S; Åhrén C; Jirholt P; Ekberg-Jansson A; Lindén A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1253-63. PubMed ID: 26170654
[TBL] [Abstract][Full Text] [Related]
8. Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD.
Holz O; Roepcke S; Watz H; Tegtbur U; Lahu G; Hohlfeld JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1393-402. PubMed ID: 26229458
[TBL] [Abstract][Full Text] [Related]
9. Alternative poly-adenylation modulates α1-antitrypsin expression in chronic obstructive pulmonary disease.
Lackey L; Coria A; Ghosh AJ; Grayeski P; Hatfield A; Shankar V; Platig J; Xu Z; Ramos SBV; Silverman EK; Ortega VE; Cho MH; Hersh CP; Hobbs BD; Castaldi P; Laederach A
PLoS Genet; 2021 Nov; 17(11):e1009912. PubMed ID: 34784346
[TBL] [Abstract][Full Text] [Related]
10. Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?
De Soyza J; Pye A; Turner AM
Expert Opin Emerg Drugs; 2023 Dec; 28(4):227-231. PubMed ID: 38112023
[No Abstract] [Full Text] [Related]
11. The influence of cigarette smoking on gingival bleeding and serum concentrations of haptoglobin and alpha 1-antitrypsin.
Al-Bayaty FH; Baharuddin N; Abdulla MA; Ali HM; Arkilla MB; ALBayaty MF
Biomed Res Int; 2013; 2013():684154. PubMed ID: 24286083
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of two strategies directed at disruption of pathogenic neutrophil extracellular vesicles in a murine emphysema model.
Genschmer KR; Madison M; Viera L; Margaroli C; Gaggar A; Blalock JE; Russell DW
Am J Physiol Lung Cell Mol Physiol; 2023 May; 324(5):L694-L699. PubMed ID: 37014068
[TBL] [Abstract][Full Text] [Related]
13. Health-related Quality of Life in Alpha-1 Antitrypsin Deficiency-associated Chronic Obstructive Pulmonary Disease.
Choate R; Holm KE; Sandhaus RA; Mannino DM; Strange C
Am J Respir Crit Care Med; 2023 Nov; 208(10):1132-1134. PubMed ID: 37581489
[No Abstract] [Full Text] [Related]
14. Alpha-1 Antitrypsin Deficiency and Smoking Cessation: Tackling the Burden of COPD One Test at a Time?
Roche SM; Carroll TP; Fraughen DD; McElvaney NG
Chest; 2023 Apr; 163(4):e197. PubMed ID: 37031997
[No Abstract] [Full Text] [Related]
15. Heterozygous Genotype rs17580 AT (PiS) in
Pérez-Rubio G; Ambrocio-Ortiz E; López-Flores LA; Juárez-Martín AI; Jiménez-Valverde LO; Zoreque-Cabrera S; Galicia-Negrete G; Ramírez-Díaz ME; Cruz-Vicente F; Castillejos-López MJ; Salinas-Lara C; Hernández-Zenteno RJ; Ramírez-Venegas A; Falfán-Valencia R
Int J Chron Obstruct Pulmon Dis; 2020; 15():1181-1190. PubMed ID: 32547005
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency.
Mayer AS; Stoller JK; Vedal S; Ruttenber AJ; Strand M; Sandhaus RA; Newman LS
Int J Chron Obstruct Pulmon Dis; 2006; 1(4):485-92. PubMed ID: 18044105
[TBL] [Abstract][Full Text] [Related]
17. Increased Antielastase Activity in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
Guo J; Lodge K; Newnham M; Bunclark K; Toshner M; Morrell NW; Li W
Am J Respir Cell Mol Biol; 2018 Nov; 59(5):652-655. PubMed ID: 30382774
[No Abstract] [Full Text] [Related]
18. Neutrophil elastase inhibitors.
Groutas WC; Dou D; Alliston KR
Expert Opin Ther Pat; 2011 Mar; 21(3):339-54. PubMed ID: 21235378
[TBL] [Abstract][Full Text] [Related]
19. Aggregation of M3 (E376D) variant of alpha1- antitrypsin.
Bashir A; Hazari Y; Pal D; Maity D; Bashir S; Singh LR; Shah NN; Fazili KM
Sci Rep; 2020 May; 10(1):8290. PubMed ID: 32427833
[TBL] [Abstract][Full Text] [Related]
20. Precision medicine in chronic obstructive pulmonary disease: how far have we come?
Khan MMKS; Cole AG; Mannino DM
Curr Opin Pulm Med; 2022 Mar; 28(2):115-120. PubMed ID: 34652296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
